<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mester-Tonczar J</submitter><funding>FIBROTARGETs EU project</funding><pagination>E1180</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7463784</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(8)</volume><pubmed_abstract>Anti-fibrotic therapies are of increasing interest to combat cardiac remodeling and heart failure progression. Recently, anti-fibrotic circular RNAs (circRNAs) have been identified in human and rodent cardiac tissue. In vivo (rodent) experiments proved cardiac anti-fibrotic effects of the natural compounds bufalin and lycorine by downregulating miRNA-671-5p, associated with a theoretic increase in the tissue level of circRNA CDR1as. Accordingly, we hypothesized that both anti-fibrotic drugs may inhibit focal myocardial fibrosis of the remodeled left ventricle (LV) also in a translational large animal model of heart failure (HF). Domestic pigs were repeatedly treated with subcutaneous injections of either bufalin, lycorine, or saline, (n = 5/group) between days 7-21 post acute myocardial in</pubmed_abstract><journal>Biomolecules</journal><pubmed_title>Association between Circular RNA CDR1as and Post-Infarction Cardiac Function in Pig Ischemic Heart Failure: Influence of the Anti-Fibrotic Natural Compounds Bufalin and Lycorine.</pubmed_title><pmcid>PMC7463784</pmcid><funding_grant_id>602904</funding_grant_id><pubmed_authors>Gyongyosi M</pubmed_authors><pubmed_authors>Zlabinger K</pubmed_authors><pubmed_authors>Traxler D</pubmed_authors><pubmed_authors>Winkler J</pubmed_authors><pubmed_authors>Einzinger P</pubmed_authors><pubmed_authors>Hasimbegovic E</pubmed_authors><pubmed_authors>Thum T</pubmed_authors><pubmed_authors>Kastner N</pubmed_authors><pubmed_authors>Lukovic D</pubmed_authors><pubmed_authors>Spannbauer A</pubmed_authors><pubmed_authors>Batkai S</pubmed_authors><pubmed_authors>Mester-Tonczar J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association between Circular RNA CDR1as and Post-Infarction Cardiac Function in Pig Ischemic Heart Failure: Influence of the Anti-Fibrotic Natural Compounds Bufalin and Lycorine.</name><description>Anti-fibrotic therapies are of increasing interest to combat cardiac remodeling and heart failure progression. Recently, anti-fibrotic circular RNAs (circRNAs) have been identified in human and rodent cardiac tissue. In vivo (rodent) experiments proved cardiac anti-fibrotic effects of the natural compounds bufalin and lycorine by downregulating miRNA-671-5p, associated with a theoretic increase in the tissue level of circRNA CDR1as. Accordingly, we hypothesized that both anti-fibrotic drugs may inhibit focal myocardial fibrosis of the remodeled left ventricle (LV) also in a translational large animal model of heart failure (HF). Domestic pigs were repeatedly treated with subcutaneous injections of either bufalin, lycorine, or saline, (n = 5/group) between days 7-21 post acute myocardial in</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Aug</publication><modification>2026-05-07T15:28:56.418Z</modification><creation>2020-09-06T07:04:16Z</creation></dates><accession>S-EPMC7463784</accession><cross_references><pubmed>32823854</pubmed><doi>10.3390/biom10081180</doi></cross_references></HashMap>